CNBC's "Fast Money" Episode Summary

Title: The Health Sector’s Fear Factor… And The Last Fed Decision of 2024
Host: Melissa Lee and CNBC Roundtable
Release Date: December 13, 2024
Location: Live from Nasdaq MarketSite, Times Square, NYC

1. Introduction

Melissa Lee introduces the episode from the Nasdaq MarketSite, highlighting the key topics to be discussed:

• Struggles within the healthcare sector amid political scrutiny.
• Decline in homebuilder stocks and potential profit-taking.
• Broadcom's impressive earnings and market performance.
• Executive visits to President Elect Donald Trump and potential implications.
• Upcoming Federal Reserve decision.

Notable Quote:
"Healthcare headache. It's the worst performing ESSENCE sector this year..." – Melissa Lee [00:49]

2. Healthcare Sector Under Scrutiny

The healthcare sector is experiencing significant downturns, largely due to political actions aimed at reducing drug prices and revisiting vaccine mandates. The New York Times reported that Aaron Sery, an ally of Robert F. Kennedy Jr., is petitioning the FDA to revoke polio vaccine approvals, signaling potential challenges for vaccine manufacturers like Pfizer and Moderna.

Key Points:

• Market Impact:
  • Aaron Sery's Actions: Petitioning against multiple vaccines, raising concerns about vaccine safety ("It's one of more than a dozen vaccines he has petitioned...") [Melissa Lee, 02:46]
  • Stock Performance: Major pharmaceutical companies (Pfizer, Moderna, Sanofi) have seen significant stock declines.
  • Insurance Backlash: UnitedHealthcare and Cigna are down double digits, influenced by legislative pressures on pharmacy benefit managers.

Notable Quotes:

• "It's not simple because it's, it's complex. This is going to take years to play out in terms of policy." – Tim Seymour [02:46]
• "I think you just have to stay long." – Karen Finerman [04:01]
• "The question is whether science will take a back seat..." – Melissa Lee [07:14]

Expert Insights:

• Tim Seymour: Sees opportunity in undervalued healthcare stocks, emphasizing the importance of ignoring sensational headlines and focusing on long-term valuations. [02:46]
• Karen Finerman: Advocates for staying invested in healthcare despite negative sentiment, noting potential disconnects in medical loss ratios and continued value in the sector. [04:01]
• Bono: Highlights the nuanced stance of RFK Jr.’s allies, suggesting that not all vaccines will be revoked and emphasizes the need for transparency. [05:15]
• Dr. Peter Hotez: Discusses the scientific rebuttal against vaccine-autism claims and expresses concern over rising anti-vaccine sentiments affecting public health. [11:25]

3. Broadcom's Market Performance

Broadcom has shown remarkable growth following a stellar earnings report, tripling revenues from the previous year and surpassing a $1 trillion market cap for the first time. The panel debates whether Broadcom will continue its upward trajectory.

Key Points:

• Earnings Success:
  • Revenue Surge: Tripled from last year.
  • Market Cap Milestone: Exceeded $1 trillion.
  • Stock Performance: Shares have doubled this year.

Notable Quotes:

• "I do think it's a new winner and I do think looking out, you know, they spoke to 2027 numbers." – Steve Grasso [19:05]
• "Pfizer or Broadcom?" – Melissa Lee [20:45]

Expert Insights:

• Steve Grasso: Predicts Broadcom as a new market leader, potentially overtaking Nvidia due to its focus on customized silicon solutions for large language models. [19:05]
• Tim Seymour: Endorses Broadcom’s growth potential, citing substantial business multiples and favorable Wall Street analyst expectations. [19:17]
• Karen Finerman: Highlights the strategic positioning of Broadcom and its capability to adapt to evolving market needs. [20:33]

4. Homebuilders' Decline and Market Strategies

The homebuilding sector has fallen over 7% this month, marking its worst performance since early 2022. The panel discusses whether this trend warrants exiting the sector or finding strategic entry points.

Key Points:

• Sector Performance:
  • Major Players: Toll Brothers down over 13%, KB Home and Pulte also experiencing significant losses.
  • Chartmaster's Outlook: Advises caution, anticipating further declines.
  • Interest Rates Impact: Rising rates have negatively affected homebuilder margins, especially those offering mortgage buydowns.

Notable Quotes:

• "It's gonna be tough for a homebuilder, but if you own a home, I think you have an easier job selling the home that you're actually in." – Bono [24:14]
• "The last thing I'll say is listen to Tim's point... present some trading opportunities in the short term." – Steve Grasso [25:04]

Expert Insights:

• Tim Seymour: Points out the challenges of high mortgage rates and saturation in rental markets, suggesting limited upside for homebuilders. [24:30]
• Steve Grasso: Suggests selective investing in homebuilders due to favorable supply-demand dynamics despite overall sector weakness. [25:04]
• Karen Finerman: Sees potential in related sectors like Home Depot and Lowe’s despite homebuilders’ struggles, owing to a strong economy and persistent inventory. [25:23]

5. Vaccine Debate and Scientific Validity

A significant portion of the episode delves into the controversy surrounding vaccines, particularly the claims linking vaccines to autism. Dr. Peter Hotez provides a scientific perspective debunking these claims and underscores the importance of maintaining robust vaccine research and trust.

Key Points:

• RFK Jr.'s Position: Continues to challenge vaccine safety, focusing on polio and other vaccines, which fuels public skepticism.
• Scientific Rebuttal: Dr. Hotez emphasizes extensive research disproving any vaccine-autism link and highlights genetic factors in autism. He warns of rising vaccine-preventable diseases due to declining vaccination rates.

Notable Quotes:

• "There's no there there." – Dr. Peter Hotez [14:17]
• "We've had polio in the wastewater in New York State in 2022..." – Dr. Peter Hotez [15:03]

Expert Insights:

• Dr. Peter Hotez: Highlights the comprehensive studies disproving vaccine-autism links and expresses concern over increasing outbreaks of preventable diseases due to anti-vaccine activism. [11:26]
• Bono: Discusses the nuanced stance of RFK Jr.’s allies, indicating that not all vaccines will be revoked and emphasizing the necessity for transparency in vaccine development. [05:15]

6. Federal Reserve's Final 2024 Decision

As the year wraps up, the Federal Reserve is poised to make its last rate decision of 2024. The panel discusses potential outcomes and their implications for the market.

Key Points:

• Potential Outcomes:
  • Rate Cuts: Market expects another rate cut, which could signal an end to the Fed's easing cycle.
  • Economic Indicators: Current strong economy with rising inflation and steady unemployment influence the Fed's stance.

Notable Quotes:

• "The market is very convinced that the Fed will cut rates." – Ben Emmons [31:51]
• "If you're going to keep cutting rates, you are assimilating the economy that makes the dollar stronger but also lift rates higher." – Ben Emmons [34:12]

Expert Insights:

• Ben Emmons (Fed Watch Adviser): Predicts a hawkish rate cut, followed by a potential hold, influenced by strong economic data and upcoming geopolitical events like the debt ceiling discussions. [31:51]
• Karen Finerman: Suggests a dovish pause would be optimal, indicating mixed expectations about the Fed's actions. [32:52]
• Tim Seymour: Highlights the strengthening dollar and its implications for multinationals and bond yields, suggesting the dollar may continue to rise. [35:16]

7. PayPal's Strategic Moves and Market Position

PayPal has recently received an upgrade from Wolf Research, with expectations of further growth driven by its expanding user base and new product monetization strategies.

Key Points:

• Stock Performance:
  • Current Movement: Shares closed up nearly 2%, with a year-end price target set at $107.
  • User Growth: From 200 million to 220 million monthly active users.

Notable Quotes:

• "So the story here, Wolf's highlighting a couple of things. 200 million to 220 million..." – Tim Seymour [28:52]
• "With a conversion rate around 45 or 50%, that's material." – Steve Grasso [30:23]

Expert Insights:

• Tim Seymour: Commends PayPal's user base expansion and strategic product enhancements, reinforcing its dominant market position. [28:52]
• Steve Grasso: Emphasizes the effectiveness of PayPal’s new payment solutions and its competitive moat due to high switching costs. [30:23]
• Karen Finerman: Observes that despite competitive threats from Apple Pay, PayPal’s entrenched user base provides stability. [30:42]

8. Big Tech's Political Maneuvering

The episode touches on how major tech companies are engaging politically, notably through donations to President Elect Trump’s inauguration fund, signaling strategic positioning ahead of the new administration.

Key Points:

• Corporate Donations:
  • Meta, Amazon, OpenAI: Each contributed $1 million to the inauguration fund, a significant increase compared to previous administrations.
  • Strategic Intent: Aimed at securing favorable relations and influence with the incoming administration amidst regulatory challenges.

Notable Quotes:

• "This won't guarantee them protection in the next administration, but $1 million is small stakes for them." – PJM Representative [39:19]
• "These are the rules of engagement for me. It's like they're protecting their downside if you don't donate." – Steve Grasso [43:18]

Expert Insights:

• PJM Representative: Analyzes the strategic nature of the donations, comparing them to past and highlighting their significance relative to company growth. [39:19]
• Karen Finerman: Discusses the importance of maintaining strong relationships with the administration for corporate interests. [42:49]
• Tim Seymour: Draws parallels between tech companies' donations and oligarchs' political strategies, emphasizing transparency in corporate political engagements. [43:26]

9. Upcoming Earnings Reports and Market Expectations

Looking ahead, the panel discusses the impact of forthcoming earnings reports from major companies like Nike and FedEx, which have shown divergent performance this year.

Key Points:

• Nike: Down nearly 30% year-to-date, handling leadership changes with a new CEO.
• FedEx: Up double digits, seen as a barometer for economic health.

Notable Quotes:

• "FedEx I think will be really interesting...the commentary will really matter." – Karen Finerman [44:15]
• "But I think the next couple of quarters are rough." – Tim Seymour [45:10]

Expert Insights:

• Karen Finerman: Anticipates strong commentary from FedEx, reflecting broader economic trends, which will influence future quarters. [44:15]
• Tim Seymour: Warns of challenging quarters ahead for Nike despite its strong brand position, advising caution on chasing the stock. [45:10]
• Steve Grasso: Suggests potential trading opportunities in FedEx due to its role as an economic indicator. [45:09]

10. Closing Remarks and Final Trades

The episode concludes with final market thoughts and strategic trades recommended by the panel.

Key Points:

• Stock Highlights:
  • Tesla: Up 12%, reaching new all-time highs.
  • Alphabet (Google): Continues to offer upside despite negative headlines.
  • Lamb Weston & Supermicro: Mixed performance based on acquisition rumors and financial strategies.

Notable Quotes:

• "I think Alphabet still offers you that upside because of the negative headline list." – Steve Grasso [46:17]
• "These are the rules of engagement for me." – Steve Grasso [43:18]

Expert Insights:

• Steve Grasso: Advocates for Alphabet due to its resilience against negative news, suggesting it remains a strong investment choice. [46:17]
• Karen Finerman: Remains bullish on PayPal’s prospects, contrasting it with diversions in other sectors. [46:17]

Conclusion

This episode of CNBC's "Fast Money" delves into the complexities facing the healthcare sector amid political pressures, evaluates Broadcom's market ascent, scrutinizes the struggling homebuilding industry, and navigates the intricate landscape of vaccine debates and political affiliations in big tech. The panel provides nuanced insights into potential investment opportunities and risks, offering valuable guidance for investors navigating a tumultuous market environment heading into the new year.

Disclaimer:
All opinions expressed by the Fast Money participants are solely their own and do not reflect the opinions of CNBC, NBC Universal, or their affiliates. Viewers should conduct their own research before making investment decisions.